Functional MRI to determine severity of cirrhosis

  • Research type

    Research Study

  • Full title

    Prediction of outcomes in cirrhosis using novel Magnetic Resonance Imaging biomarkers of liver function

  • IRAS ID

    224109

  • Contact name

    Ian Rowe

  • Contact email

    i.a.c.rowe@leeds.ac.uk

  • Sponsor organisation

    University of Leeds

  • Clinicaltrials.gov Identifier

    NCT03623360

  • Duration of Study in the UK

    0 years, 6 months, 3 days

  • Research summary

    The clinical outcome for patients with liver disease is determined by the degree of scarring in the liver. If it is severe, then this is termed cirrhosis and complications of liver disease may occur. Prediction of when these complications will arise is challenging and at present requires a combination of tests, including blood tests, ultrasound scans and endoscopy tests.\n\nWe have recently developed a novel technique to characterize liver function based on Dynamic Contrast Enhanced (DCE) MRI. DCE-MRI uses a liver specific contrast agent that demonstrates blood flow into liver cells, and measures the cells ability to absorb nutrients and eliminate waste products, reflecting liver function and perfusion across the whole liver.\n\nUsing DCE-MRI in combination with measures of fibrosis and blood flow through the liver derived from the same MRI, offers the potential for a “one-stop“ assessment of liver function and the future risk of complications.\n\nThe aim of this pilot study is to evaluate this MRI technique in patients with cirrhosis. Specifically we will assess: \n1. Whether sufficient data can be generated in patients with cirrhosis whilst maintaining image quality, \n2. The dynamic range of DCE-MRI measures in patients with cirrhosis, and\n3. The correlation of the DCE-MRI measures with clinical outcomes.\n\nThis pilot study will, if successful, provide sufficient data to support applications for larger studies to evaluate the clinical utility of a DCE-MRI imaging biomarker in patients with cirrhosis.\n\nImaging will take place in the recently completed MRC National Centre for Hyperpolarized MRI, at the Advanced Imaging Centre of the Leeds General Infirmary. This is equipped with a state-of-the-art 3T Siemens MRI scanner and supported by an on-site Siemens collaboration manager.

  • REC name

    Yorkshire & The Humber - Leeds West Research Ethics Committee

  • REC reference

    18/YH/0375

  • Date of REC Opinion

    19 Oct 2018

  • REC opinion

    Favourable Opinion